RecruitingNCT05918367

Multicenter Ventral Mesh Rectopexy Registry Collaborative


Sponsor

University Hospital, Antwerp

Enrollment

200 participants

Start Date

Sep 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this multicenter observational study is to collect data prospectively of patients with pelvic organ prolapse undergoing ventral mesh rectopexy (as well as rectoceles, entero-/sigmoidoceles/ intussusception/ rectal prolapse or combined) by laparoscopy or robotic surgery and to evaluate the longterm functional outcomes. Secondly complications (mesh erosions, recurrence, reoperations) are evaluated. Following main questions will be analysed - other can follow in consultation with the collaborative 1. Is VMR the technique of choice for treatment of rectoceles? Functional results - recurrence - mesh related complications 2. Has a perineal descent an impact on the functional outcome of ventral mesh rectopexy perfored for external rectal prolaps, internal rectal prolaps, rectocele, enterocele, sigmoidcele or combined pelvic organ prolapse?


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Diagnosis of posterior pelvic organ prolaps planned for laparoscopie or robotic ventral mesh rectopexy with or without concomittant surgery.
  • All patients 18 years or older and are able to complete a written informed conscent are eligble for inclusion.

Exclusion Criteria4

  • Inability to complete a written informed conscent
  • Pregnant women
  • No email adress available to send the questionnaires to
  • Language barrier or impossiblity to fill in the questionnaires (at the discretion oft he treating physician)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

UZ Brussel

Brussels, Belgium

University Hospital Antwerp

Edegem, Belgium

AZ Jan Palfijn

Ghent, Belgium

Jessa ziekenhuis

Hasselt, Belgium

AZ Delta Roeselare

Roeselare, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05918367


Related Trials